前列腺特异性膜抗原在双下肢淋巴水肿中的蓄积
本文报道一例前列腺癌伴转移性淋巴结相关双下肢淋巴水肿患者,在静脉Lu-PSMA治疗后全身扫描中,双下肢出现皮肤回流及软组织摄取。提示Lu-PSMA治疗后显像可见淋巴水肿相关PSMA蓄积,解读时应与肿瘤摄取鉴别。
要点
- Lu-PSMA治疗后全身扫描可显示淋巴水肿相关PSMA蓄积
- 淋巴水肿区域可表现为皮肤回流及软组织摄取
- 解读Lu-PSMA治疗后显像需与肿瘤摄取相鉴别
核心结论
- 前列腺癌伴转移性淋巴结相关双下肢淋巴水肿患者,Lu-PSMA治疗后全身扫描可见双下肢皮肤回流和软组织PSMA蓄积。
研究设计与样本
- 本文为个案报道,描述一例接受静脉Lu-PSMA治疗的前列腺癌伴转移性淋巴结相关双下肢淋巴水肿患者。
主要发现
- 该患者Lu-PSMA治疗后全身扫描显示双下肢皮肤回流及软组织摄取。
临床怎么用
- 解读Lu-PSMA治疗后全身扫描时,应识别淋巴水肿相关皮肤回流和软组织摄取,避免误判为肿瘤病灶。
局限性
- 本文为单个病例报道,未报告定量摄取、剂量学或对照影像数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate-specific membrane antigen (PSMA) is overexpressed in a majority of prostate cancer cells, which has led to the development of radiolabeled small-molecule inhibitors of PSMA for molecular imaging and targeted radioligand therapy. Lu-labeled PSMA, with therapeutic β-emission and concomitant γ radiation, permits posttherapy imaging for the assessment of biodistribution and uptake in tumors and normal organs, as well as dosimetry. We report a patient with prostate cancer and metastatic lymph nodes-related lower extremity lymphedema, who presented with dermal backflow and soft-tissue uptake in the lower extremity on posttherapeutic whole body scan after intravenous Lu-PSMA treatment.
引用
- Zhang J, Kulkarni HR, Singh A, et al. Prostate-Specific Membrane Antigen Accumulation in Lower Extremity Lymphedema. Clin Nucl Med. 2019. PMID: 30932981. doi:10.1097/RLU.0000000000002552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。